Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Sampson O. et al, (2022), J Immunol Methods, 504
Tomic A. et al, (2022), Nature Communications, 13
Townsend A. et al, (2021), Nature Communications, 12
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.
Skelly DT. et al, (2021), Nature communications, 12
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
Skelly DT. et al, (2021), Nature Communications, 12
Ahern DJ. et al, (2021)
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults.
Riste M. et al, (2021), Vaccines, 9
Chen B. et al, (2021), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 104, 77 - 82
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
Eyre DW. et al, (2020), eLife, 9
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Song R. et al, (2020), The Journal of infection
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.
Fidler S. et al, (2020), Lancet (London, England), 395, 888 - 898
Self-maintaining CD103+ cancer-specific T cells are highly energetic with rapid cytotoxic and effector responses
Abd Hamid M. et al, (2019), Cancer Immunology Research, canimm.0554.2019 - canimm.0554.2019
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
Li X. et al, (2019), Frontiers in Oncology, 9
Enriched HLA-E and CD94/NKG2a interaction limits anti-tumor CD8(+) tumor-infiltrating T lymphocyte responses
Abd Hamid MHB. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1252 - 1253
Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses
Abd Hamid M. et al, (2019), Cancer Immunology Research, canimm.0885.2018 - canimm.0885.2018
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study.
Whitworth HS. et al, (2019), The Lancet. Infectious diseases, 19, 193 - 202